New biological targets behind Alzheimer's disease

Harnessing new targets and mechanisms mediating AD pathogenesis

NIH-funded research University of Florida · NIH-11231228

This project looks for genes and pathways tied to Alzheimer's that could point to new treatments for people with the disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida NIH-funded
Lab location1 site (Gainesville, United States)
Project IDNIH-11231228 on NIH RePORTER

What this research studies

Researchers created a fruit fly model that carries human amyloid-beta and tau proteins to mimic key features of Alzheimer's. They turned off thousands of genes in the flies to see which changes make the brain damage better or worse, discovering dozens of candidate genes. The work is done in the lab using these animal models and does not enroll patients. Findings may point scientists toward new drug targets or biomarkers to test in people later on.

Who could benefit from this research

Good fit: This is a laboratory study using model organisms and does not enroll patients for participation.

Not a fit: People looking for immediate treatments or clinical care are unlikely to benefit directly from this basic research right now.

Why it matters

Potential benefit: Could reveal new targets that researchers can develop into treatments to slow or prevent Alzheimer's progression.

How similar studies have performed: Genetic screens in model organisms have previously identified disease-related genes, but translating fly discoveries into human therapies is an early and uncertain process.

Where this research is happening

Gainesville, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer disease treatment
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.